Last news
INLIF LIMITED Reports Fiscal Year 2024 Financial Results

INLIF LIMITED Reports Fiscal Year 2024 Financial Results

QUANZHOU, China, April 30, 2025 /PRNewswire/ -- INLIF LIMITED (Nasdaq: INLF) (the "Company" or "INLIF"), a company engaged in the research, development, manufacturing, and sales of injection molding machine-dedicated manipulator arms, today...

Appian Celebrates 2025 Innovation Award Winners

Appian Celebrates 2025 Innovation Award Winners

Customers Delivered Value with Process Orchestration and AI Capabilities on the Appian Platform SYDNEY, April 30, 2025 /PRNewswire/ -- Appian (Nasdaq: APPN) today announced the 2025 Appian Innovation Awards winners at Appian World, its annual global...

UNLIMEAT Rolls Out Its Bold Korean Plant-Based Meats at Kroger

UNLIMEAT Rolls Out Its Bold Korean Plant-Based Meats at Kroger

The innovative Korean brand introduces its plant-based Bulgogi and Pulled Pork to over 300 Kroger stores nationwide With demand for Korean flavors at an all-time high, UNLIMEAT brings authentic taste and sustainability to mainstream grocery aisles...

Appian Customers Unlock AI's Full Potential by Embedding It in Business Processes

Appian Customers Unlock AI's Full Potential by Embedding It in Business Processes

DENVER, April 30, 2025 /PRNewswire/ -- Appian (Nasdaq: APPN) is giving customers the power to have AI work directly in their business processes. As the Process Company, Appian believes better processes are the key to better business outcomes. AI...

Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies

Innovent Announces First Patient Dosed in Phase 1 Study of IBI3020, Global First-in-class Dual Payload CEACAM5 ADC, in Patients with Advanced Malignancies

SAN FRANCISCO and SUZHOU, China, April 30, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...

Appian Embeds Agentic AI into Business Processes to Deliver Scalable, Governable Enterprise Value

Appian Embeds Agentic AI into Business Processes to Deliver Scalable, Governable Enterprise Value

Introducing new AI features and Data Fabric enhancements to deliver real-time insights and measurable impact. SYDNEY, April 30, 2025 /PRNewswire/ -- Appian (NASDAQ: APPN) today announced agentic AI platform enhancements to help organisations build,...

137th Canton Fair Phase 2 Highlights Quality Home Life Through Innovation and Green Thinking

137th Canton Fair Phase 2 Highlights Quality Home Life Through Innovation and Green Thinking

GUANGZHOU, China, April 30, 2025 /PRNewswire/ -- Phase 2 of the 137th China Import and Export Fair (Canton Fair), taking place from April 23 to 27, spans an impressive 515,000 square meters of exhibition space. With 10,313 participating companies,...

Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Hong Kong

Everest Medicines Announces New Drug Application Approval of VELSIPITY® for Adults with Moderately to Severely Active Ulcerative Colitis in Hong Kong

SHANGHAI, April 30, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics,...

1 ... 464 465 466 467 468 469 470 471 472 ... 2867
menu
menu